REFERENCES
1. F. Zhou, presention at the 45th National Immunization Conference (Washington, DC, March 2011).
2. US Dept. of Health and Human Services, 2010 National Vaccine Plan,
http://www.hhs.gov/nvpo/vacc_plan/2010%20Plan/nationalvaccineplan.pdf, accessed Sept. 10, 2012.
3. Health Industry Distributors Association, 2010–2011 Influenza Vaccine Production and Distribution Market Brief (Sept.
2011).
4. C.C. Pereira and D. Bishai, Expert Reviews 9 (11), 1343–1349 (2010).
5. CDC, The Pink Book—Epidemiology and Prevention of Vaccine-Preventable Diseases, W. Atkinson, S. Wolfe, and J. Hamborsky,
eds, (Public Health Foundation, 12th ed., Washington DC, 2011).
6. D. Bishai, presentation at the World Vaccine Congress, (Washington DC, Apr. 2010).
7. Advisory Committee on Immunization Practices, MMWR 55 (RR15), 1–48 (2006).
8. G. Pugliese et al., Am J Infect Control 38 (10), 789–98 (2010).
9. New York State Department of Health, "Nassau County and State Health Departments Alert 36 Patients to Infection Control
Error by Long Island Doctor," Press Release, Albany, NY, Jan. 15, 2008.
10. Experts123, "Why is Human Factors Engineering Important for Medical Devices?" http://www.experts123.com/q/why-is-human-factors-engineering-important-for-medical-devices.html, accessed Sept. 24, 2012.
11. Interface Analysis Associates, Vaccine Primary Drug Container: Single-Dose, Multi-Dose, Pre-Filled Syringe Risks Analysis
Report. On file at BD (2011).
12. Company Reports, IMS Data, National Influenza Vaccine Summits, BD Market Intelligence (2006–2012).
13. BD Market Intelligence (2009).
|
